WhichRecall
Class IIReported 2024-12-18

Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0378-1807-77) and b) 1000-count bottles (NDC 0378-1807-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Recalled by Viatris Inc

Reason for Recall

Superpotent Drug and Subpotent Drug: potency failures obtained

Advertisement
Recall Number
D-0126-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2024-11-18
Reported
2024-12-18
Distribution
Nationwide within the United States and Puerto Rico
Code Info
Lot # a) 8180781, Exp. Date Aug 2025; b)3191628, Exp. Date Feb 2025; 3197139, Exp. Date Apr 2025; 3188976, Exp. Date Jan 2025; 3184929, Exp. Date Dec 2024; 3204909, Exp. Date Aug 2025
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement